Skip to content

Clinical trials

Hypertension, Pulmonary trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Country / region: Mexico Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20061
20084
20095
20121
20143
20152
20161
20171
20192
20202
20214
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated6
Active, not recruiting5
Unknown status3
Withdrawn1
Enrolling by invitation1
No longer available1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
United Therapeutics5
Merck Sharp & Dohme LLC3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Biogen2
Gilead Sciences2
Pfizer2
Actelion1
Asociacion Latinoamericana de Torax1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary33
Pulmonary Arterial Hypertension17
Cardiovascular Diseases3
Hypertension3
Lung Diseases3
Vascular Diseases3
Connective Tissue Diseases2
Familial Primary Pulmonary Hypertension2
Lung Diseases, Interstitial2
Respiratory Tract Diseases2

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.